Trial of propranolol in acute myocardial infarction.

No abstract is available for this paper.

• Publication year

  1968

• Venue

  British medical journal

• Publication date

  1968-05-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/bmj.2.5602.398PMID 4870075PMCID PMC1985983
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The coronary care unit. New perspectives and directions.

  1967cited by this paper
• A controlled trial of propranolol in acute myocardial infarction.

  1966cited by this paper
• Absence of prophylactic effect of propranolol in myocardial infarction.

  1966cited by this paper
• Mortality Reduction in a Coronary Care Unit

  1966cited by this paper
• Effect of propranolol in myocardial infarction.

  1965cited by this paper
• Clinical experiences with propranolol.

  1965cited by this paper
• Propranolol (Inderal) in Persistent Ventricular Fibrillation

  1965cited by this paper
• CARDIOVASCULAR EFFECTS OF ANOXIA AND THE INFLUENCE OF A NEW BETA ADRENERGIC RECEPTOR BLOCKING DRUG.

  1965cited by this paper
• Effect of Propranolol (Inderal) in Angina Pectoris: Preliminary Report

  1964cited by this paper

• Finn Waagstein and the paradigm shift in the treatment of heart failure with β-adrenergic receptor antagonists (‘β-blockers’)

  2025cites this paper
• Beta-Adrenergic Blockers for Acute Myocardial Infarction: 50 years of Expert Opinions in Cecil Textbook of Medicine

  2025cites this paper
• Through the Decades: &bgr;-Blocker Use and Outcomes in Acute Coronary Syndromes

  2018cites this paper
• Beta-blockers for suspected or diagnosed acute myocardial infarction.

  2016cites this paper
• Clinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials.

  2014cites this paper
• CRITICAL CARE THERAPEUTICS

  2013cites this paper
• β-Adrenergic Receptor Blocking Drugs in Cardiac Arrhythmias

  2012cites this paper
• The effect of beta-blockade on ST segment elevation after acute myocardial infarction in man with some experimental observations.

  2009cites this paper
• Spontaneous Hypoglycemia with Special Reference to the Diagnosis of Hyperinsulinism

  2009cites this paper
• Use of alprenolol in the secondary prevention of myocardial infarction.

  2009cites this paper
• V Prophylactic Effect of Alprenolol on Ventricular Tachyarrhythmias during the In‐Patient Phase of Acute Myocardial Infarction

  2009cites this paper
• I Background and Aims of the Study

  2009cites this paper
• The effect of long-term intervention with alprenolol on mortality in definite or suspected myocardial infarction.

  2009cites this paper
• VII Causes of Death and Post-Mortem Findings with Special Reference to Early Deaths

  2009cites this paper
• Acute intervention with metoprolol in myocardial infarction.

  2009cites this paper
• Do beta-blockers reduce short-term mortality following acute myocardial infarction? A systematic review and meta-analysis.

  2008cites this paper
• Do β-blockers reduce short-term mortality following acute myocardial infarction? A systematic review and meta-analysis

  2008cites this paper
• [Beta receptor blockers and calcium antagonists in coronary disease. Differential therapeutic aspects].

  2008cites this paper
• Drug Class Review on Beta Adrenergic Blockers: Final Report

  2007cites this paper
• ACUTE MYOCARDIAL INFARCTION BY APPUCATION OF HEMODYNAMIC SUBSETS

  2006cites this paper
• P-BLOCKADE AFTER MYOCARDIAL INFARCTION-A STATISTICAL VIEW

  2006cites this paper
• Drug Class Review on Beta Adrenergic Blockers

  2005cites this paper
• Effect of long-term beta-blockade with alprenolol on platelet function and fibrinolytic activity in patients with coronary heart disease

  2004cites this paper
• [Recommendations of the French Society of Cardiology concerning the treatment of myocardial infarction after the acute phase. Epidemiology and Prevention Group].

  2001cites this paper
• Recommandations de la Société française de cardiologie concernant la prise en charge de l'infarctus du myocarde après la phase aiguë

  2001cites this paper
• beta Blockade after myocardial infarction: systematic review and meta regression analysis.

  1999cites this paper
• Increased survival with beta-blockers: importance of ancillary properties.

  1997cites this paper
• Increased survival with β-blockers: Importance of ancillary properties

  1997cites this paper
• Choosing the Right β-Blocker

  1994cites this paper
• Choosing the right beta-blocker. A guide to selection.

  1994cites this paper
• The status of calcium antagonists in the drug treatment of coronary heart disease

  1989cites this paper
• Beta-blockade in acute myocardial infarction.

  1988cites this paper
• Class II antiarrhythmic agents.

  1988cites this paper
• Determinants of salvage of jeopardized myocardium after coronary thrombolysis.

  1987cites this paper
• Complexity and contradiction in clinical trial research.

  1987cites this paper
• Stellenwert der Kalziumantagonisten in der medikamentösen Therapie der koronaren Herzkrankheit

  1987cites this paper
• Beneficial effects of timolol on infarct size and late ventricular tachycardia in patients with acute myocardial infarction.

  1987cites this paper
• Management of a patient recovering from myocardial infarction: a decision tree.

  1986cites this paper
• Early use of beta-adrenergic-blocking agents in acute myocardial infarction.

  1986cites this paper
• 8 – Mechanisms and Management of Myocardial Infarction Arrhythmias

  1986cites this paper
• Early Use of β -Adrenergic-Blocking Agents in Acute Myocardial Infarction

  1986cites this paper
• Pathophysiology of myocardial reperfusion.

  1985cites this paper
• Primary and secondary prevention of coronary artery disease by drug therapy

  1985cites this paper
• Beta blockade during and after myocardial infarction: an overview of the randomized trials.

  1985cites this paper
• Secondary prevention after myocardial infarction: Subgroup analysis of patients at risk in the norwegian timolol multicenter study

  1985cites this paper
• Use of beta-adrenergic blocking agents after myocardial infarction.

  1985cites this paper
• Clinical Trials of Modification of Mortality During Acute Myocardial Infarction

  1985cites this paper
• The Use of β-Adrenergic and Calcium-Blocking Drugs During Acute Myocardial Ischemia and Infarction

  1985cites this paper
• Reduction of infarct size with the early use of timolol in acute myocardial infarction.

  1984cites this paper
• β-Adrenergic Blockade for Survivors of Acute Myocardial Infarction

  1984cites this paper
• Effect of acute and long-term beta-adrenergic blockade with alprenolol in definite or suspected myocardial infarction. Causes of death and post-mortem findings with special reference to early deaths.

  1984cites this paper
• The use of β-adrenergic blocking drugs in patients with myocardial infarction

  1984cites this paper
• [Secondary prevention of myocardial infarct with anti-arrhythmia drugs and beta receptor blockaders].

  1984cites this paper
• Myokard İnfarktüslü Hastaların Tedavisinde Beta-Blokörlerin Yeri

  1984cites this paper
• [Secondary prevention of myocardial infarction using anti-arrhythmia agents and beta-receptor blockers].

  1984cites this paper
• Beta-adrenergic blockade for survivors of acute myocardial infarction.

  1984cites this paper
• Secondary Prevention After Myocardial Infarction: Facts and Fallacies

  1984cites this paper
• Status of beta blocker therapy in acute myocardial infarction.

  1984cites this paper
• Prophylactic use of beta-adrenergic blockade in survivors of myocardial infarction.

  1984cites this paper
• Secondary prevention after myocardial infarction: a review of short-term acute phase trials.

  1983cites this paper
• Beta adrenoceptor antagonists after myocardial infarction--where are we now?

  1983cites this paper
• Beta blocking agents in the treatment of hypertension.

  1983cites this paper
• 3 – Pharmacologic Approaches to the Prevention of Myocardial Infarction and Sudden Death

  1983cites this paper
• The natural history of coronary artery disease: does medical therapy improve the prognosis?

  1983cites this paper
• Beta-adrenoceptor blockade and myocardial infarction: when should treatment start and for how long should it continue?

  1983cites this paper
• Role of beta-adrenergic blockade in the therapy of patients with myocardial infarction.

  1983cites this paper
• Reduction of ventricular arrhythmias by early intravenous atenolol in suspected acute myocardial infarction.

  1983cites this paper
• Clinical use of antiarrhythmic drugs

  1983cites this paper
• Do Beta-Blockers Prolong Life?

  1982cites this paper
• BETA BLOCKING AGENTS: CURRENT STATUS IN THE PREVENTION OF SUDDEN CORONARY DEATH *

  1982cites this paper
• Beta-blockade after myocardial infarction--a statistical view.

  1982cites this paper
• A long-term prevention study with oxprenolol in coronary heart disease.

  1982cites this paper
• THERAPEUTIC PROGRESS—REVIEW III * CAN DRUGS PREVENT RECURRENT MYOCARDIAL INFARCTION?

  1982cites this paper
• beta-Blockers and myocardial infarction.

  1982cites this paper
• [Effect on mortality of metoprolol in acute myocardial infarction. A randomized double-blind trial (author's transl)].

  1982cites this paper
• Confidence in results of beta-blocker postinfarction trials.

  1982cites this paper
• ß-Blockers and Myocardial Infarction

  1982cites this paper
• The question posed in the title of my talk has not really been

  1982cites this paper
• Decreasing Myocardial Energy Utilization

  1982cites this paper
• β-Rezeptorenblocker bei und nach Herzinfarkt

  1982cites this paper
• Long-term and short-term beta-blockade after myocardial infarction.

  1982cites this paper
• Clinical Features of Adrenergic Agonists and Antagonists

  1981cites this paper
• Chronic Beta Blockade after Myocardial Infarction

  1981cites this paper
• Möglichkeiten und Risiken der β-Blockade beim akuten Myokardinfarkt

  1981cites this paper
• Catecholamines and the Heart

  1981cites this paper
• Clinical experience with beta adrenergic blocking agents in myocardial ischaemia: a dilemma and a challenge.

  1981cites this paper
• 15 – β-Adrenergic Antagonists in Angina and Myocardial Infarction

  1981cites this paper
• Efforts to limit the size of myocardial infarcts.

  1981cites this paper
• Myocardial Infarction and Beta-Adrenoceptor Blockade

  1981cites this paper
• Postinfarction Intervention Studies with Propranolol and Atenolol: Problems in Design and Interpretation

  1981cites this paper
• Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial.

  1981cites this paper
• Increased plasma propranolol binding in myocardial infarction.

  1980cites this paper
• Comparison of newer antiarrhythmic agents.

  1980cites this paper
• Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 12. Beta-adrenoceptor blockade in myocardial infarction: the continuing controversy.

  1980cites this paper
• Metoprolol and atropine in acute myocardial infarction.

  1980cites this paper
• Early intravenous atenolol treatment in suspected acute myocardial infarction. Preliminary report of a randomised trial.

  1980cites this paper
• Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy, and Yugoslavia.

  1980cites this paper
• Neural Factors and Ventricular Electrical Instability

  1980cites this paper
• Rest and the acutely ischaemic heart.

  1980cites this paper
• Antiarrhythmic action of adrenergic beta-receptor blocking agents.

  1980cites this paper